JCI - Citations to Rapamycin inhibits vascular smooth muscle cell migration.

Citations to this article

Rapamycin inhibits vascular smooth muscle cell migration.

M Poon, … , M B Taubman, A R Marks

M Poon, … , M B Taubman, A R Marks

Published November 15, 1996
Citation Information: J Clin Invest. 1996;98(10):2277-2283. https://doi.org/10.1172/JCI119038.

View: Text | PDF

Research Article

Total citations by year

Year:	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	Total
Citations:	5	4	3	5	4	4	8	7	10	16	10	19	15	22	21	22	21	28	19	27	29	25	21	17	10	6	4	382

Citation information

Citations to this article (382)

Title and authors	Publication	Year
Endovascular Drug Delivery Lungu CN, Creteanu A, Mehedinti MC	Life Sciences	2024
Yohimbine Inhibits PDGF-Induced Vascular Smooth Muscle Cell Proliferation and Migration via FOXO3a Factor Lim L, Kim H, Jeong J, Han SH, Yu YB, Song H	International journal of molecular sciences	2024
mTOR signalling controls the formation of smooth muscle cell-derived luminal myofibroblasts during vasculitis. Stock AT, Parsons S, Hansen JA, D'Silva DB, Starkey G, Fayed A, Lim XY, D'Costa R, Gordon CL, Wicks IP	EMBO reports	2024
Self-expanding intracranial drug-eluting stent system in patients with symptomatic intracranial atherosclerotic stenosis: initial experience and midterm angiographic follow-up. Zhang F, Yao J, Wu P, Wu Q, Li C, Yang J, Liu Y, Gareev I, Shi H, Wang C	Neuroradiology	2024
The impact of drug eluting stents on the co-release of interleukin-6 in patients with stable angina Albadri Z, Almousali R, Abdulla S	Global Cardiology Science & Practice	2024
Acute aortic dissection caused by fruquintinib for metastatic colorectal cancer-a case report and literature review. Deng YY, Chen YW, Wang MX, Zhu PF, Pan SY, Jiang DY, Chen ZL, Yang L	Translational cancer research	2023
The Effects of Sirolimus and Magnesium on Primary Human Coronary Endothelial Cells: An In Vitro Study. Fedele G, Castiglioni S, Maier JAM, Locatelli L	International journal of molecular sciences	2023
The mammalian target of rapamycin contributes to synovial fibroblast pathogenicity in rheumatoid arthritis. Barker BE, Hanlon MM, Marzaioli V, Smith CM, Cunningham CC, Fletcher JM, Veale DJ, Fearon U, Canavan M	Frontiers in Medicine	2023
A noncommutative combinatorial protein logic circuit controls cell orientation in nanoenvironments. Chen J, Vishweshwaraiah YL, Mailman RB, Tabdanov ED, Dokholyan NV	Science Advances	2023
Cardiovascular effects of immunosuppression agents Elezaby A, Dexheimer R, Sallam K	Frontiers in Cardiovascular Medicine	2022
Anemoside B4 Inhibits Vascular Smooth Muscle Cell Proliferation, Migration, and Neointimal Hyperplasia. Shan D, Qu P, Zhong C, He L, Zhang Q, Zhong G, Hu W, Feng Y, Yang S, Yang XF, Yu J	Frontiers in Cardiovascular Medicine	2022
Vascular Calcification: In Vitro Models under the Magnifying Glass. Ceccherini E, Cecchettini A, Gisone I, Persiani E, Morales MA, Vozzi F	Biomedicines	2022
Roles of mTOR in thoracic aortopathy understood by complex intracellular signaling interactions AC Estrada, L Irons, BV Rego, G Li, G Tellides, JD Humphrey, JR Faeder	PLoS computational biology	2021
Vascular Lesion–Specific Drug Delivery Systems D Marlevi, ER Edelman	Journal of the American College of Cardiology	2021
Do we really understand how drug eluted from stents modulates arterial healing? A McQueen, J Escuer, A Aggarwal, S Kennedy, C McCormick, K Oldroyd, S McGinty	International Journal of Pharmaceutics	2021
Sirolimus Treatment in Sturge-Weber Syndrome AJ Sebold, AM Day, J Ewen, J Adamek, A Byars, B Cohen, EH Kossoff, T Mizuno, M Ryan, J Sievers, L Smegal, SJ Suskauer, C Thomas, A Vinks, TA Zabel, AM Hammill, AM Comi	Pediatric Neurology	2021
mTORC1 (Mechanistic Target of Rapamycin Complex 1) Signaling in Endothelial and Smooth Muscle Cells Is Required for Vascular Function JJ Reho, DF Guo, DA Morgan, K Rahmouni	Hypertension	2021
The quest for effective pharmacological suppression of neointimal hyperplasia MP McMonagle	Current Problems in Surgery	2020
Clickable, acid labile immunosuppressive prodrugs for in vivo targeting H Wang, MC Sobral, T Snyder, Y Brudno, VS Gorantla, DJ Mooney	Biomaterials Science	2020
Adventitial injection delivery of nano-encapsulated sirolimus (Nanolimus) to injury-induced porcine femoral vessels to reduce luminal restenosis HY Ang, GM Xiong, SY Chaw, JL Phua, JC Ng, PE Wong, S Venkatraman, TT Chong, Y Huang	Journal of Controlled Release	2020
The Effects of Long-Term Immunosuppressive Therapies on the Structure of the Rat Prostate M Grabowska, M Laszczyńska, K Kędzierska-Kapuza, A Kram, K Gill, M Piasecka	International journal of environmental research and public health	2020
TOR as a Regulatory Target in Rhipicephalus microplus Embryogenesis C Waltero, LA de Abreu, T Alonso, R Nunes-da-Fonseca, , C Logullo	Frontiers in physiology	2019
Activation of TFEB ameliorates dedifferentiation of arterial smooth muscle cells and neointima formation in mice with high-fat diet YT Wang, X Li, J Chen, BK McConnell, L Chen, PL Li, Y Chen, Y Zhang	Cell Death and Disease	2019
Recent advances in the role of mammalian target of rapamycin inhibitors on cardiac allograft vasculopathy L Bellumkonda, J Patel	Clinical Transplantation	2019
Drug-Coated Balloons: Applications in Interventional Cardiology B Cortese		2019
40 Years of Percutaneous Coronary Intervention: History and Future Directions J Canfield, H Totary-Jain	Journal of Personalized Medicine	2018
Upregulation of miR-221 and -222 in response to increased extracellular signal-regulated kinases 1/2 activity exacerbates neointimal hyperplasia in diabetes mellitus DJ Lightell, SC Moss, TC Woods	Atherosclerosis	2018
Notoginsenoside R1 inhibits vascular smooth muscle cell proliferation, migration and neointimal hyperplasia through PI3K/Akt signaling H Fang, S Yang, Y Luo, C Zhang, Y Rao, R Liu, Y Feng, J Yu	Scientific Reports	2018
Sirolimus-eluting Biodegradable Poly- l -Lactic Acid Stent to Suppress Granulation Tissue Formation in the Rat Urethra KY Kim, JH Park, DH Kim, J Tsauo, MT Kim, WC Son, SG Kang, DH Kim, HY Song	Radiology	2018
Anti-Inflammatory Effect of Gallic Acid-Eluting Stent in a Porcine Coronary Restenosis Model Kyung Seob Lim, Jun-Kyu Park, Myung Ho Jeong, In Ho Bae, Dae Sung Park, Jae Won Shim, Jung Ha Kim, Hyun Kuk Kim, Sung Soo Kim, Doo Sun Sim, Young Joon Hong, Ju Han Kim, Youngkeun Ahn	ACTA CARDIOL SIN	2018
Inhibition of 5‐Hydroxytryptamine Receptor 2B Reduced Vascular Restenosis and Mitigated the β‐Arrestin2–Mammalian Target of Rapamycin/p70S6K Pathway Y Liu, Z Wang, J Li, Y Ban, G Mao, M Zhang, M Wang, Y Liu, B Zhao, Q Shen, Q Xu, N Wang	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease	2018
Intracoronary imaging to guide percutaneous coronary intervention: Clinical implications G Scalone, G Niccoli, OG Monterrosas, P Grossi, A Aimi, L Mariani, LD Vito, K Kuku, F Crea, HM Garcia-Garcia	International Journal of Cardiology	2018
Long-term clinical outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer sirolimus-eluting stents. Chung J, Lim WH, Seo JB, Chung WY		2018
Opposing Actions of AKT (Protein Kinase B) Isoforms in Vascular Smooth Muscle Injury and Therapeutic ResponseHighlights Y Jin, Y Xie, AC Ostriker, X Zhang, R Liu, MY Lee, KL Leslie, W Tang, J Du, SH Lee, Y Wang, WC Sessa, J Hwa, J Yu, KA Martin	Arteriosclerosis, thrombosis, and vascular biology	2017
Inhibition of the mTOR pathway in abdominal aortic aneurysm: implications of smooth muscle cell contractile phenotype, inflammation, and aneurysm expansion G Li, L Qin, L Wang, X Li, AW Caulk, J Zhang, PY Chen, S Xin	American journal of physiology. Heart and circulatory physiology	2017
Effect of sirolimus on arteriosclerosis induced by advanced glycation end products via inhibition of the ILK/mTOR pathway in kidney transplantation recipients Z Xu, X Liu, Z Wang, J Tao, Z Han, M Gu, W Zhang, R Tan	European Journal of Pharmacology	2017
Understanding the effect of magnesium degradation on drug release and anti-proliferation on smooth muscle cells for magnesium-based drug eluting stents Y Shi, J Pei, L Zhang, BK Lee, Y Yun, J Zhang, Z Li, S Gu, K Park, G Yuan	Corrosion Science	2017
Biomaterial Mechanics HN Hayenga, H Aranda-Espinoza		2017
Rapamycin-loaded nanoporous α-Fe 2 O 3 as an endothelial favorable and thromboresistant coating for biodegradable drug-eluting Fe stent applications M Li, X Xu, Z Jia, Y Shi, Y Cheng, Y Zheng	Journal of Materials Chemistry B	2017
Dual TORCs driven and B56 orchestrated signaling network guides eukaryotic cell migration Lou W Kim	BMB Reports	2017
The roles of autophagy in vascular smooth muscle cells S Tai, XQ Hu, DQ Peng, SH Zhou, XL Zheng	International Journal of Cardiology	2016
Sustained delivery by a cyclodextrin material-based nanocarrier potentiates antiatherosclerotic activity of rapamycin via selectively inhibiting mTORC1 in mice Y Dou, J Guo, Y Chen, S Han, X Xu, Q Shi, Y Jia, Y Liu, Y Deng, R Wang, X Li, J Zhang	Journal of Controlled Release	2016
Use of Brilliant Blue FCF during vein graft preparation inhibits intimal hyperplasia MJ Osgood, K Sexton, I Voskresensky, K Hocking, J Song, P Komalavilas, C Brophy, J Cheung-Flynn	Journal of Vascular Surgery	2016
Biosynthetic Polymers for Medical Applications K Udipi	Biosynthetic Polymers for Medical Applications	2016
A comparison of drug-eluting stent versus balloon angioplasty in patients with bare-metal stent instent restenosis: 5year outcomes A Yıldız, C Yıldız, V Oduncu, AO Çimen	International Journal of the Cardiovascular Academy	2016
Is It Time to Use De Novo mTOR Inhibitors Posttransplant? GJ McKenna	Current Transplantation Reports	2016
Effects of an immunosuppressive treatment on the rat prostate M Grabowska, K Kędzierska, K Michałek, S Słuczanowska-Głąbowska, M Grabowski, M Piasecka, A Kram, I Rotter, A Ryl, M Laszczyńska	Drug design, development and therapy	2016
Comparison of dextran-based sirolimus-eluting stents and PLA-based sirolimus-eluting stents in vitro and in vivo: COMPARISON OF DEXTRAN-BASED AND PLA-BASED SIROLIMUS-ELUTING STENTS SY Lee, IH Bae, DS Park, EJ Jang, JW Shim, KS Lim, JK Park, DS Sim, MH Jeong	Journal of biomedical materials research. Part A	2016
Interventional Cardiology: Principles and Practice GD Dangas, CD Mario, NN Kipshidze, P Barlis, T Addo, PW Serruys	Interventional Cardiology: Principles and Practice	2016
Coronary Graft Failure IC Ţintoiu, MJ Underwood, SP Cook, H Kitabata, A Abbas		2016
Advances in Experimental Medicine and Biology G Santulli	Advances in experimental medicine and biology	2015
Advances in Experimental Medicine and Biology G Santulli	Advances in experimental medicine and biology	2015
Advances in Experimental Medicine and Biology G Santulli	Advances in experimental medicine and biology	2015
Advances in Experimental Medicine and Biology G Santulli	Advances in experimental medicine and biology	2015
Advances in Experimental Medicine and Biology G Santulli	Advances in experimental medicine and biology	2015
Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential C Spitz, H Winkels, C Bürger, C Weber, E Lutgens, GK Hansson, N Gerdes	Cellular and Molecular Life Sciences	2015
Phosphorylation of GATA-6 is required for vascular smooth muscle cell differentiation after mTORC1 inhibition Y Xie, Y Jin, BL Merenick, M Ding, KM Fetalvero, RJ Wagner, A Mai, S Gleim, DF Tucker, MJ Birnbaum, BA Ballif, AK Luciano, WC Sessa, EM Rzucidlo, RJ Powell, L Hou, H Zhao, J Hwa, J Yu, KA Martin	Science signaling	2015
Effects of Combining Rapamycin and Resveratrol on Apoptosis and Growth of TSC2-Deficient Xenograft Tumors A Alayev, RS Salamon, Y Sun, NS Schwartz, C Li, JJ Yu, MK Holz	American journal of respiratory cell and molecular biology	2015
Comparison of phytoncide with sirolimus as a novel drug candidate for drug-eluting stent SN Kang, SE Kim, J Choi, K Park, JH Goo, DS Sim, YJ Hong, JH Kim, YK Joung, J Lee, MH Jeong, DK Han	Biomaterials	2015
The Suppression of Wound Healing Response with Sirolimus and Sunitinib Following Experimental Trabeculectomy in a Rabbit Model K Eren, B Turgut, MM Akin, T Demir	Current Eye Research	2015
The wound healing response after implantation of a drug-eluting stent is impaired persistently in the long term T Nasuno, M Tokura, M Kageyama, S Toyoda, M Sakuma, T Komatsu, I Taguchi, S Abe, T Inoue	Heart and Vessels	2015
An in silico study on the role of smooth muscle cell migration in neointimal formation after coronary stenting H Tahir, I Niculescu, C Bona-Casas, RM Merks, AG Hoekstra	Journal of The Royal Society Interface	2015
Optimization of Drug Delivery by Drug-Eluting Stents F Bozsak, D Gonzalez-Rodriguez, Z Sternberger, P Belitz, T Bewley, JM Chomaz, AI Barakat, MR Mofrad	PloS one	2015
Comparison of the performance of zotarolimus- and everolimus-eluting stents by optical coherence tomography and coronary angioscopy T Masawa, S Abe, S Toyoda, M Sakuma, T Nasuno, M Kageyama, M Tokura, S Koizumi, I Taguchi, T Inoue	Heart and Vessels	2015
Multiple noncovalent interactions mediated one-pot therapeutic assemblies for the effective treatment of atherosclerosis Y Dou, X Zhang, X Xu, X Zhou, S Han, R Wang, M Su, X Li, J Zhang	Journal of Materials Chemistry B	2015
Controversies in Cardiology JA Ambrose, AE Rodríguez		2015
Chronic allograft rejection: A significant hurdle to transplant success M Kloc, RM Ghobrial	Burns & Trauma	2014
Rapamune Does Not Attenuate High Cholesterol-Induced Atherosclerosis in Rabbits A Attia, M Ahmed, S Ng, K Prasad, A Shoker	International Journal of Angiology	2014
The preclinical evaluation of the dual mTORC1/2 inhibitor INK-128 as a potential anti-colorectal cancer agent C Li, JF Cui, MB Chen, CY Liu, F Liu, QD Zhang, J Zou, PH Lu	Cancer biology & therapy	2014
Macromolecular Approaches to Prevent Thrombosis and Intimal Hyperplasia Following Percutaneous Coronary Intervention RA Scott, A Panitch	Biomacromolecules	2014
Local Delivery of Antiproliferative Agents via Stents H Kwon, S Park	Polymers	2014
Connexin 43 Gene Therapy Delivered by Polymer-Modified Salmonella in Murine Tumor Models WK Wang, YD Kuan, CY Kuo, CH Lee	Polymers	2014
RNAi-based functional selection identifies novel cell migration determinants dependent on PI3K and AKT pathways M Seo, S Lee, JH Kim, WH Lee, G Hu, SJ Elledge, K Suk	Nature Communications	2014
An increase of VEGF plasma levels is associated with restenosis of drug-eluting stents KM Katsaros, SP Kastl, KA Krychtiuk, R Hutter, G Zorn, G Maurer, K Huber, J Wojta, G Christ, WS Speidl	EuroIntervention	2014
Pharmacological inhibition of coronary restenosis: systemic and local approaches E Guerra, RA Byrne, A Kastrati	Expert Opinion on Pharmacotherapy	2014
Rapamycin Represses Myotube Hypertrophy and Preserves Viability of C2C12 Cells During Myogenesis In Vitro: H Gao, M Ao, H Wang, L Yu	Transplantation	2014
AKT2 Confers Protection Against Aortic Aneurysms and Dissections YH Shen, L Zhang, P Ren, MT Nguyen, S Zou, D Wu, XL Wang, JS Coselli, SA LeMaire	Circulation research	2013
Tailoring mTOR-based therapy: molecular evidence and clinical challenges G Santulli, H Totary-Jain	Pharmacogenomics	2013
The late-phase inflammatory response after drug-eluting stent implantation I Taguchi, S Yoneda, S Abe, S Toyoda, T Nasuno, S Nishino, M Kageyama, M Tokura, M Ogawa, K Node, T Inoue	Heart and Vessels	2013
Implications of autophagy for vascular smooth muscle cell function and plasticity JK Salabei, BG Hill	Free radical biology & medicine	2013
In vitro mutagenicity and blood compatibility of paclitaxel and curcumin in poly (dl-lactide-co-glicolide) films IL Vieira, DC de Souza, LS Coelho, LC Chen, LA Guillo	Toxicology in Vitro	2013
Cardiovascular Therapeutics: A Companion to Braunwald's Heart Disease A Wang, EW Seely, SA Karumanchi	Cardiovascular Therapeutics: A Companion to Braunwald's Heart Disease	2013
MicroRNA-21 mediates the rapamycin-induced suppression of endothelial proliferation and migration C Jin, Y Zhao, L Yu, S Xu, G Fu	FEBS Letters	2013
Sirolimus and Cardiovascular Disease Risk in Liver Transplantation: GJ McKenna, JF Trotter, E Klintmalm, R Ruiz, N Onaca, G Testa, G Saracino, MF Levy, RM Goldstein, GB Klintmalm	Transplantation	2013
Coronary stents: historical development, current status and future directions J Iqbal, J Gunn, PW Serruys	British Medical Bulletin	2013
MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer cells MB Chen, MX Wei, JY Han, XY Wu, C Li, J Wang, W Shen, PH Lu	Cellular Signalling	2013
A Comparative, Randomized Trial of Concentration-Controlled Sirolimus Combined With Reduced-Dose Tacrolimus or Standard-Dose Tacrolimus in Renal Allograft Recipients WO Bechstein, L Paczek, L Wramner, JP Squifflet, AJ Zygmunt	Transplantation Proceedings	2013
Systematic Review of Effectiveness of Oral Sirolimus After Bare-Metal Stenting of Coronary Arteries for Prevention of In-Stent Restenosis TW Dasari, B Patel, JF Saucedo	The American Journal of Cardiology	2013
Cardiac Allograft Vasculopathy by Intravascular Ultrasound in Heart Transplant Patients: Substudy From the Everolimus versus Mycophenolate Mofetil Randomized, Multicenter Trial JA Kobashigawa, DF Pauly, RC Starling, H Eisen, H Ross, SS Wang, B Cantin, JA Hill, P Lopez, G Dong, SJ Nicholls	JACC: Heart Failure	2013
Prospective randomized trial of maintenance immunosuppression with rapid discontinuation of prednisone in adult kidney transplantation TM Suszynski, KJ Gillingham, MD Rizzari, TB Dunn, WD Payne, S Chinnakotla, EB Finger, DE Sutherland, JS Najarian, TL Pruett, AJ Matas, R Kandaswamy	American Journal of Transplantation	2013
Effects of rapamycin on granulation formation in response to centrally doubled coiled stents as a tracheal substitute M Kubota, Y Matsuda, S Fujimaki, M Osawa, T Wakai, K Nakaya	Journal of Pediatric Surgery	2013
Empiric switch from calcineurin inhibitor to sirolimus-based immunosuppression in pediatric heart transplantation recipients RW Loar, DJ Driscoll, SS Kushwaha, CH Cramer, PW O'Leary, RC Daly, DA Mauriello, JN Johnson	Pediatric Transplantation	2013
Relative resistance to Mammalian target of rapamycin inhibition in vascular smooth muscle cells of diabetic donors DJ Lightell, TC Woods	The Ochsner journal	2013
A Finite Element Study on Variations in Mass Transport in Stented Porcine Coronary Arteries Based on Location in the Coronary Arterial Tree JT Keyes, BR Simon, JP Geest	Journal of Biomechanical Engineering	2013
Implant-associated local drug delivery systems based on biodegradable polymers: customized designs for different medical applications K Sternberg, S Petersen, N Grabow, V Senz, HM zu Schwabedissen, HK Kroemer, KP Schmitz	Biomedizinische Technik/Biomedical Engineering	2013
Motility, Survival and Proliferation WT Gerthoffer, D Schaafsma, P Sharma, S Ghavami, AJ Halayko	Comprehensive Physiology	2012
Pathologic Etiologies of Late and Very Late Stent Thrombosis following First-Generation Drug-Eluting Stent Placement F Otsuka, M Nakano, E Ladich, FD Kolodgie, R Virmani	Thrombosis	2012
Low-Dose Rapamycin Treatment Increases the Ability of Human Regulatory T Cells to Inhibit Transplant Arteriosclerosis In Vivo J Hester, A Schiopu, SN Nadig, KJ Wood	American Journal of Transplantation	2012
The Generations of Drug-Eluting Stents and Outcomes in Women VG Ng, AJ Lansky	Interventional Cardiology Clinics	2012
Stent elution rate determines drug deposition and receptor-mediated effects AR Tzafriri, A Groothuis, GS Price, ER Edelman	Journal of Controlled Release	2012
TNF-α promotes human retinal pigment epithelial (RPE) cell migration by inducing matrix metallopeptidase 9 (MMP-9) expression through activation of Akt/mTORC1 signaling C Wang, GF Cao, Q Jiang, J Yao	Biochemical and Biophysical Research Communications	2012
Tumor necrosis factor-alpha (TNF-α)-mediated in vitro human retinal pigment epithelial (RPE) cell migration mainly requires Akt/mTOR complex 1 (mTORC1), but not mTOR complex 2 (mTORC2) signaling Y Liu, GF Cao, J Xue, J Wan, Y Wan, Q Jiang, J Yao	European Journal of Cell Biology	2012
Water soluble polymer films for intravascular drug delivery of antithrombotic biomolecules RA Scott, K Park, A Panitch	European Journal of Pharmaceutics and Biopharmaceutics	2012
Effect of everolimus on pre-existing atherosclerosis in LDL-receptor deficient mice F Beutner, D Brendel, D Teupser, K Sass, R Baber, M Mueller, U Ceglarek, J Thiery	Atherosclerosis	2012
Modeling and rescue of the vascular phenotype of Williams-Beuren syndrome in patient induced pluripotent stem cells C Kinnear, WY Chang, S Khattak, A Hinek, T Thompson, DC Rodrigues, K Kennedy, N Mahmut, P Pasceri, WL Stanford, J Ellis, S Mital	Stem Cells Translational Medicine	2012
Targeted Treatments for Restenosis and Vein Graft Disease AC Thomas	ISRN Vascular Medicine	2012
Biodegradable stent DY Kwon, JI Kim, DY Kim, HJ Kang, B Lee, KW Lee, MS Kim	Journal of Biomedical Science and Engineering	2012
TGF-β and Smad3 modulate PI3K/Akt signaling pathway in vascular smooth muscle cells PA Suwanabol, SM Seedial, F Zhang, X Shi, Y Si, B Liu, KC Kent	American journal of physiology. Heart and circulatory physiology	2012
Molecular and Translational Vascular Medicine JW Homeister, MS Willis		2012
Diabetes and Peripheral Vascular Disease GV Shrikhande, JF McKinsey		2012
Vascular smooth muscle cell proliferation in restenosis SO Marx, H Totary-Jain, AR Marks	Circulation. Cardiovascular interventions	2011
mTOR and the differentiation of mesenchymal stem cells X Xiang, J Zhao, G Xu, Y Li, W Zhang	Acta Biochimica et Biophysica Sinica	2011
Interventional Cardiology G Sangiorgi, A Mauriello, S Trimarchi, E Bonanno, LG Spagnoli	Interventional Cardiology	2011
Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts J Zou, X Zhang, H Yang, Y Zhu, H Ma, S Wang	Journal of Cardiothoracic Surgery	2011
Stent thrombosis and drug-eluting stents T Takayama, T Hiro, A Hirayama	Journal of Cardiology	2011
Candesartan With Pioglitazone Protects Against Endothelial Dysfunction and Inflammatory Responses in Porcine Coronary Arteries Implanted With Sirolimus-Eluting Stents T Dohi, K Miyauchi, T Iesaki, R Tsuruta, S Tsuboi, M Ogita, N Kubota, T Kasai, T Yokoyama, H Daida	Circulation Journal	2011
Low-dose sirolimus combined with angiotensin-converting enzyme inhibitor and statin stabilizes renal function and reduces glomerular proliferation in poor prognosis IgA nephropathy JM Cruzado, R Poveda, M Ibernon, M Diaz, X Fulladosa, M Carrera, J Torras, O Bestard, I Navarro, J Ballarin, R Romero, JM Grinyo	Nephrology Dialysis Transplantation	2011
Rapamycin-Loaded Nanoparticles for Inhibition of Neointimal Hyperplasia in Experimental Vein Grafts J Zou, X Zhang, H Yang, Y Zhu, H Ma, S Wang	Annals of Vascular Surgery	2011
Drug-Eluting Stent H Hao, H Ishibashi-Ueda, M Tsujimoto, Y Ueda, J Shite, G Gabbiani, K Fujii, S Hirota	Circulation Journal	2011
Inhibition of human in-stent restenosis: a molecular view A Giordano, A Romano	Current Opinion in Pharmacology	2011
Use of remote film loading methodology to entrap sirolimus into liposomes: Preparation, characterization and in vivo efficacy for treatment of restenosis A Haeri, S Sadeghian, S Rabbani, MS Anvari, MA Boroumand, S Dadashzadeh	International Journal of Pharmaceutics	2011
How safe and how good are drug-eluting stents? AM Kabir, A Selvarajah, AM Seifalian	Future Cardiology	2011
TOR kinase complexes and cell migration L Liu, CA Parent	The Journal of Cell Biology	2011
Anesthesia for Organ Transplantation VL Scott, KM Wahl, K Soltys, KG Belani, DS Beebe, PJ Davis	Smith s Anesthesia for Infants and Children	2011
Effect of recombinant human SDF-1a on re-endothelialization after sirolimus-eluting stent implantation in rabbit aorta abdominalis L Zhang, J Zhu, R Du, Z Zhu, J Zhang, W Han, R Zhang	Life Sciences	2011
Paclitaxel and sirolimus differentially affect growth and motility of endothelial progenitor cells and coronary artery smooth muscle cells Y Clever, B Cremers, B Krauß, M Böhm, U Speck, U Laufs, B Scheller	EuroIntervention	2011
Liposomal alendronate for the treatment of restenosis D Gutman, G Golomb	Journal of Controlled Release	2011
Drug-eluting Stent Restenosis: Effect of Drug Type, Release Kinetics, Hemodynamics and Coating Strategy MI Papafaklis, YS Chatzizisis, KK Naka, GD Giannoglou, LK Michalis	Pharmacology & Therapeutics	2011
Role of mTOR Signaling in Tumor Cell Motility, Invasion and Metastasis H Zhou, S Huang	Current protein & peptide science	2011
Inhibition de l’hyperplasie néointimale des greffes veineuses expérimentales par des nanoparticules chargées de rapamycine J Zou, X Zhang, H Yang, Y Zhu, H Ma, S Wang	Annales de Chirurgie Vasculaire	2011
Granulocyte-macrophage colony-stimulating factor (GM-CSF): a chemoattractive agent for murine leukocytes in vivo M Khajah, B Millen, DC Cara, C Waterhouse, DM McCafferty	Journal of leukocyte biology	2011
Mechanism and in Vitro Release Kinetic Study of Sirolimus from a Biodegradable Polymeric Matrix Coated Cardiovascular Stent A Raval, J Parikh, C Engineer	Industrial & engineering chemistry research	2011
Pharmacological prevention and management of restenosis KA Tiroch, RA Byrne, A Kastrati	Expert Opinion on Pharmacotherapy	2010
Loss of Canonical Insulin Signaling Accelerates Vascular Smooth Muscle Cell Proliferation and Migration Through Changes in p27Kip1 Regulation DJ Lightell, SC Moss, TC Woods	Endocrinology	2010
Coronary late lumen loss of drug eluting stents is associated with increased serum levels of the complement components C3a and C5a WS Speidl, KM Katsaros, SP Kastl, G Zorn, K Huber, G Maurer, J Wojta, G Christ	Atherosclerosis	2010
Plasminogen activator inhibitor-1 and vitronectin expression level and stoichiometry regulate vascular smooth muscle cell migration through physiological collagen matrices N Garg, N Goyal, TL Strawn, J Wu, KM Mann, DA Lawrence, WP Fay	Journal of Thrombosis and Haemostasis	2010
Tumor Suppressor Serine/Threonine Kinase LKB1 Expression, Not Kinase Activity, Increased in the Vascular Smooth Muscle Cells and Neointima in the Rat Carotid Artery Injury Model JO Jeong, JH Kim, KT Ahn, HS Park, WI Jang, JH Park, JH Lee, SW Choi, JM Kim, IW Seong	Korean Circulation Journal	2010
Drug-eluting stents X Ma, T Wu, MP Robich, X Wang, H Wu, B Buchholz, S McCarthy	International journal of clinical and experimental medicine	2010
The effects of rapamycin on lens epithelial cell proliferation, migration, and matrix formation: an in vitro study H Liu, G Feng, L Wu, S Fu, P Liu, W Yang, X Zhang	Molecular vision	2010
mTOR signaling in cancer cell motility and tumor metastasis H Zhou, S Huang	Critical reviews in eukaryotic gene expression	2010
Rapamycin inhibits re-endothelialization after percutaneous coronary intervention by impeding the proliferation and migration of endothelial cells and inducing apoptosis of endothelial progenitor cells HT Liu, F Li, WY Wang, XJ Li, YM Liu, RA Wang, WY Guo, HC Wang	Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital	2010
Perivascular fat-mediated vascular dysfunction and remodeling through the AMPK/mTOR pathway in high-fat diet-induced obese rats L Ma, S Ma, H He, D Yang, X Chen, Z Luo, D Liu, Z Zhu	Hypertension Research	2010
The Changes of Slit Diaphragm Molecules After Using Sirolimus JY Choi, GD Han, YJ Kim, YH Park	Journal of the Korean Society of Pediatric Nephrology	2010
Coronary Stents S Garg, PW Serruys	Journal of the American College of Cardiology	2010
Predictive value of C-reactive protein after drug-eluting stent implantation RA Montone, G Ferrante, M Bacà, G Niccoli	Future Cardiology	2010
Preparation, characterization and in vitro anticoagulation of emodin-eluting controlled biodegradable stent coatings CJ Pan, J Wang, N Huang	Colloids and Surfaces B: Biointerfaces	2010
Increased serum vWF and sVCAM-1 levels are associated with late or very late angiographic stent thrombosis after sirolimus-eluting stent implantation C Jin, L Lu, ZB Zhu, RY Zhang, Q Zhang, R Du, FH Ding, QJ Chen, WF Shen	Coronary Artery Disease	2010
Increased Restenosis Rate After Implantation of Drug-Eluting Stents in Patients With Elevated Serum Activity of Matrix Metalloproteinase-2 and -9 KM Katsaros, SP Kastl, G Zorn, G Maurer, J Wojta, K Huber, G Christ, WS Speidl	JACC: Cardiovascular Interventions	2010
Comprehensive Toxicology JM Sands, JW Verlander	Comprehensive Toxicology	2010
Impaired Peroxisome Proliferator-activated Receptor-γ Contributes to Phenotypic Modulation of Vascular Smooth Muscle Cells during Hypertension L Zhang, P Xie, J Wang, Q Yang, C Fang, S Zhou, J Li	The Journal of biological chemistry	2010
Sirolimus Eluting Stents PP Hu, E Mahmud	Clinical medicine insights. Therapeutics	2010
Biodegradable Sirolimus-loaded Poly(lactide) Nanoparticles as Drug Delivery System for the Prevention of In-Stent Restenosis in Coronary Stent Application F Luderer, M Löbler, HW Rohm, C Gocke, K Kunna, K Köck, HK Kroemer, W Weitschies, KP Schmitz, K Sternberg	Journal of Biomaterials Applications	2010
Monitoring Molecular-Specific Pharmacodynamics of Rapamycin In vivo with Inducible Gal4 → Fluc Transgenic Reporter Mice MH Pan, J Lin, JL Prior, D Piwnica-Worms	Molecular cancer therapeutics	2010
Smooth muscle Notch1 mediates neointimal formation after vascular injury Y Li, K Takeshita, PY Liu, M Satoh, N Oyama, Y Mukai, MT Chin, L Krebs, MI Kotlikoff, F Radtke, T Gridley, JK Liao	Circulation	2009
Signaling Pathways Regulating Vascular Smooth Muscle Cell Differentiation EM Rzucidlo	Vascular	2009
Molecular Basis of Restenosis and Novel Issues of Drug-Eluting Stents T Inoue, K Node	Circulation Journal	2009
In-vitro Release of Rapamycin from a Thermosensitive Polymer for the Inhibition of Vascular Smooth Muscle Cell Proliferation W Zhu, T Masaki, AK Cheung, SE Kern	Journal of bioequivalence & bioavailability	2009
Morelloflavone blocks injury-induced neointimal formation by inhibiting vascular smooth muscle cell migration D Pinkaew, SG Cho, DY Hui, JE Wiktorowicz, N Hutadilok-Towatana, W Mahabusarakam, M Tonganunt, LJ Stafford, A Phongdara, M Liu, K Fujise	Biochimica et Biophysica Acta (BBA) - General Subjects	2009
Spreading of mesothelioma cells is rapamycin-sensitive and requires continuing translation E Ranzato, S Grosso, M Patrone, PG Betta, A Viarengo, S Biffo	Journal of Cellular Biochemistry	2009
Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR III (Oral Rapamycin in ARgentina) study A Rodriguez, A Maree, S Tarragona, C Fernandez-Pereira, O Santaera, AR Granillo, G Rodriguez-Granillo, M Russo-Felssen, N Kukreja, D Antoniucci, I Palacios, P Serruys	EuroIntervention	2009
Rapamycin—rather than FK506—might promote allograft tolerance induced by CD4+CD25+ regulatory T cells JF Du, SY Li, B Yu	Surgery	2009
Systemic rapamycin without loading dose for restenosis prevention after coronary bare metal stent implantation S Stojkovic, M Ostojic, M Nedeljkovic, G Stankovic, B Beleslin, V Vukcevic, D Orlic, A Arandjelovic, J Kostic, M Dikic, M Tomasevic	Catheterization and Cardiovascular Interventions	2009
Therapeutic role of sirolimus in non-transplant kidney disease GK Rangan, T Nguyen, R Mainra, L Succar, KG Schwensen, JS Burgess, KO Ho	Pharmacology & Therapeutics	2009
ADENOVIRUS-MEDIATED FKBP12.6 OVEREXPRESSION INDUCES HYPERTROPHY AND APOPTOSIS IN CULTURED NEONATAL CARDIOMYOCYTES J Zhong, J Chen, T Cao, L Wang, W Zhang, D Liu, Z Zhu	Clinical and Experimental Pharmacology and Physiology	2009
Passive and Active Polymer Coatings for Intracoronary Stents: Novel Devices to Promote Arterial Healing L Pendyala, R Jabara, K Robinson, N Chronos	Journal of Interventional Cardiology	2009
Comparison of the Systemic Levels of Inflammatory Markers after Percutaneous Coronary Intervention with Bare Metal versus Sirolimus-Eluting Stents AG Rebeiz, E Zoghbi, R Harb, S Youhanna, HN Skouri, A Dimassi, G Abou-Nader, A Nasrallah, J Sawaya, W Gharzuddine, S Alam	Journal of Interventional Cardiology	2009
Optimization of Plasma Treatment, Manipulative Variables and Coating Composition for the Controlled Filling and Coating of a Microstructured Reservoir Stent M Mekki, S Durual, SS Scherrer, J Lammers, HW Wiskott	Journal of Medical Devices	2009
A new strategy for prevention of anastomotic stricture using tacrolimus-eluting biodegradable nanofiber M Mutsuga, Y Narita, A Yamawaki, M Satake, H Kaneko, Y Suematsu, A Usui, Y Ueda	The Journal of Thoracic and Cardiovascular Surgery	2009
Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor L Zhao, T Ding, T Cyrus, Y Cheng, H Tian, M Ma, R Falotico, D Praticò	British Journal of Pharmacology	2009
Pharmacology and Therapeutics BL Clarke, S Khosla	Pharmacology & Therapeutics	2009
New approach for local delivery of rapamycin by bioadhesive PLGA-carbopol nanoparticles W Zou, G Cao, Y Xi, N Zhang	Drug Delivery	2009
Emerging drugs for coronary restenosis: the role of systemic oral agents the in stent era AE Rodriguez	Expert Opinion on Emerging Drugs	2009
Oral rapamycin attenuates atherosclerosis without affecting the arterial responsiveness of resistance vessels in apolipoprotein E-deficient mice AL Gadioli, BV Nogueira, RM Arruda, RB Pereira, SS Meyrelles, JA Arruda, EC Vasquez	Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas / Sociedade Brasileira de Biofisica ... [et al.]	2009
Drug-Eluting Stent for Delivery of Signal Pathway-Specific 1,3-Dipropyl-8-cyclopentyl Xanthine E Kang, K Vedantham, X Long, M Dadara, IK Kwon, M Sturek, K Park	Molecular Pharmaceutics	2009
Device Therapy in Heart Failure WH Maisel		2009
Leptin-enhanced neointimal hyperplasia is reduced by mTOR and PI3K inhibitors J Shan, TB Nguyen, H Totary-Jain, H Dansky, SO Marx, AR Marks	Proceedings of the National Academy of Sciences	2008
Lokale Medikamentenfreisetzung am und im Gefäß A Larena-Avellaneda, G Dittmann, R Siegel, C Haacke, ES Debus	Gefässchirurgie	2008
Cytokines and Coronary Artery Disease AA El-Menyar	Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine	2008
Migration of airway smooth muscle cells WT Gerthoffer	Proceedings of the American Thoracic Society	2008
The inhibition of insulin-stimulated proliferation of vascular smooth muscle cells by rosiglitazone is mediated by the Akt-mTOR-P70S6K pathway S Park, S Lim, W Chang, H Song, S Lee, BW Song, HJ Kim, MJ Cha, E Choi, Y Jang, N Chung, SY Cho, KC Hwang	Yonsei Medical Journal	2008
Phosphoinositide 3-kinase signalling in the vascular system F Morello, A Perino, E Hirsch	Cardiovascular Research	2008
Comparison of vasa vasorum after intravascular stent placement with sirolimis drug-eluting and bare metal stents LG Sahler, D Davis, WE Saad, NC Patel, DE Lee, DL Waldman	Journal of Medical Imaging and Radiation Oncology	2008
Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR−/− mice despite severe hypercholesterolemia MA Mueller, F Beutner, D Teupser, U Ceglarek, J Thiery	Atherosclerosis	2008
Proliferation signal inhibitors and cardiac allograft vasculopathy E Raichlin, SS Kushwaha	Current Opinion in Organ Transplantation	2008
Effects of rapamycin on intracellular cholesterol homeostasis of glomerular mesangial cell in the presence of interleukin-1β G Zhang, H Li, X Li	Chinese Medical Sciences Journal	2008
Long-Term Coronary Endothelial Function After Zotarolimus-Eluting Stent Implantation DI Shin, KB Seung, PJ Kim, K Chang, JK Choi, DS Jeon, MJ Kim, MY Lee, WS Chung	International Heart Journal	2008
Eluting characteristics of a platelet glycoprotein receptor antibody using a PLLA-coated stent GX Wang, TY Yin, LL Luo, YB Hou, YZ Wang, CG Ruan, RP Guzman, R Guidoin	Journal of Biomaterials Science, Polymer Edition	2008
Sirolimus-induced vascular dysfunction. Increased mitochondrial and nicotinamide adenosine dinucleotide phosphate oxidase-dependent superoxide production and decreased vascular nitric oxide formation A Jabs, S Göbel, P Wenzel, AL Kleschyov, M Hortmann, M Oelze, A Daiber, T Münzel	Journal of the American College of Cardiology	2008
Rapamycin inhibits proliferation and migration of hepatoma cells in vitro Y Shirouzu, E Ryschich, O Salnikova, V Kerkadze, J Schmidt, G Engelmann	The Journal of surgical research	2008
Textbook of Peripheral Vascular Interventions, Second Edition: new approaches E Kedhi, L Bilodeau	Textbook of Peripheral Vascular Interventions, Second Edition	2008
Nonimmunosuppressive effects of mammalian target of rapamycin inhibitors JM Cruzado	Transplantation Reviews	2008
Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents? FH Zhao, YD Chen, ZN Jin, SZ Lu	Medical Hypotheses	2008
Preliminary Results of the Hydroxyapatite Nonpolymer-Based Sirolimus-Eluting Stent for the Treatment of Single De Novo Coronary Lesions JR Costa, A Abizaid, R Costa, F Feres, LF Tanajura, A Abizaid, LA Mattos, R Staico, D Siqueira, AG Sousa, R Bonan, JE Sousa	JACC: Cardiovascular Interventions	2008
Drug-eluting stents—what should be improved? J Steffel, FR Eberli, TF Lüscher, FC Tanner	Annals of Medicine	2008
The critical role of the intrinsic VSMC proliferation and death programs in injury-induced neointimal hyperplasia ZH Mnjoyan, D Doan, JL Brandon, K Felix, CL Sitter, AA Rege, TA Brock, K Fujise	American journal of physiology. Heart and circulatory physiology	2008
Interventional Treatment of Advanced Ischemic Heart Disease R Delgado		2008
Rapamycin attenuates hypoxia-induced pulmonary vascular remodeling and right ventricular hypertrophy in mice R Paddenberg, P Stieger, AL Lilien, P Faulhammer, A Goldenberg, HH Tillmanns, W Kummer, RC Braun-Dullaeus	Respiratory Research	2007
Smooth muscle cell signal transduction: Implications of vascular biology for vascular surgeons A Muto, TN Fitzgerald, JM Pimiento, SP Maloney, D Teso, JJ Paszkowiak, TS Westvik, FA Kudo, T Nishibe, A Dardik	Journal of Vascular Surgery	2007
Sirolimus blocks the accumulation of hyaluronan (HA) by arterial smooth muscle cells and reduces monocyte adhesion to the ECM Y Gouëffic, S Potter-Perigo, CK Chan, PY Johnson, K Braun, SP Evanko, TN Wight	Atherosclerosis	2007
Preparation and characterization of rapamycin-loaded PLGA coating stent CJ Pan, JJ Tang, YJ Weng, J Wang, N Huang	Journal of Materials Science: Materials in Medicine	2007
Angiographic and Clinical Outcome Following Sirolimus-Eluting Stent (Cypher) Implantation T Ozcan, VG Cin, M Yurtdas, B Akcay, S Seyis, A Acele, D Cicek, A Camsari, N Akkus, O Doven	International Heart Journal	2007
Regulation of vascular smooth muscle cell differentiation EM Rzucidlo, KA Martin, RJ Powell	Journal of Vascular Surgery	2007
Sesquiterpene Lactone Suppresses Vascular Smooth Muscle Cell Proliferation and Migration via Inhibition of Cell Cycle Progression M Nakagawa, T Ohno, R Maruyama, M Okubo, A Nagatsu, M Inoue, H Tanabe, G Takemura, S Minatoguchi, H Fujiwara	Biological & Pharmaceutical Bulletin	2007
Drug-Eluting Stents L Slavin, A Chhabra, JM Tobis	Cardiology in Review	2007
Orally Administered Rapamycin Does Not Modify Rat Aortic Vascular Tone MM Neto, GS di Marco, DE Casarini, VC Lima, AH Campos	Journal of Cardiovascular Pharmacology	2007
Sirolimus-eluting coronary stents: a review A Abizaid	Vascular Health and Risk Management	2007
Coronary stents: A materials perspective G Mani, MD Feldman, D Patel, CM Agrawal	Biomaterials	2007
External Application of Rapamycin-Eluting Film at Anastomotic Sites Inhibits Neointimal Hyperplasia in a Canine Model S Kawatsu, K Oda, Y Saiki, Y Tabata, K Tabayashi	The Annals of Thoracic Surgery	2007
Improved blood compatibility of rapamycin-eluting stent by incorporating curcumin CJ Pan, JJ Tang, ZY Shao, J Wang, N Huang	Colloids and Surfaces B: Biointerfaces	2007
Enhanced inflammatory response to coronary stenting marks the development of clinically relevant restenosis AM Caixeta, FS Brito, MA Costa, CV Serrano, JL Petriz, PL da Luz	Catheterization and Cardiovascular Interventions	2007
Targeting mammalian target of rapamycin (mTOR) for health and diseases CK Tsang, H Qi, LF Liu, XF Zheng	Drug Discovery Today	2007
Clinical Use of Sirolimus-Eluting Stents AJ Kirtane, MB Leon	Cardiovascular Drug Reviews	2007
Effects of controlled-released sirolimus from polymer matrices on human coronary artery smooth muscle cells XT Wang, S Venkatraman, F Boey, SC Loo, LP Tan	Journal of Biomaterials Science, Polymer Edition	2007
Cytostatic drugs differentially affect phenotypic features of porcine coronary artery smooth muscle cell populations M Prunotto, M Bacchetta, S Jayaraman, M Galloni, GV Eys, G Gabbiani, ML Bochaton-Piallat	FEBS Letters	2007
Local vascular dysfunction after coronary paclitaxel-eluting stent implantation M Togni, L Räber, R Cocchia, P Wenaweser, S Cook, S Windecker, B Meier, OM Hess	International Journal of Cardiology	2007
The effects of granulocyte-colony stimulating factor in bare stent and sirolimus-eluting stent in pigs following myocardial infarction SY Lim, YS Kim, Y Ahn, MH Jeong, LS Rok, JH Kim, KH Kim, HW Park, W Kim, JG Cho, JC Park, PM Kang, RS Schwartz, JC Kang	International Journal of Cardiology	2007
Sirolimus-Eluting Stents vs Uncoated Stents for the Treatment of Proximal Left Anterior Descending Coronary Artery Stenosis J Valencia, V Mainar, P Bordes, A Berenguer, JM Ruiz-Nodar, J Pineda, S Gomez, F Sogorb, J Caturla	International journal of biomedical science : IJBS	2007
Sirolimus inhibits key events of restenosis in vitro/ex vivo: evaluation of the clinical relevance of the data by SI/MPL- and SI/DES-ratio's R Voisard, S Zellmann, F Müller, F Fahlisch, L Müller, R Baur, J Braun, J Gschwendt, M Kountides, V Hombach, J Kamenz	BMC Cardiovascular Disorders	2007
Rapamycin Promotes Vascular Smooth Muscle Cell Differentiation through Insulin Receptor Substrate-1/Phosphatidylinositol 3-Kinase/Akt2 Feedback Signaling KA Martin, BL Merenick, M Ding, KM Fetalvero, EM Rzucidlo, CD Kozul, DJ Brown, HY Chiu, M Shyu, BL Drapeau, RJ Wagner, RJ Powell	The Journal of biological chemistry	2007
Anti-atherosclerotic effects of sirolimus on human vascular smooth muscle cells KL Ma, XZ Ruan, SH Powis, JF Moorhead, Z Varghese	American journal of physiology. Heart and circulatory physiology	2007
The Proline-rich Akt Substrate of 40 kDa (PRAS40) Is a Physiological Substrate of Mammalian Target of Rapamycin Complex 1 N Oshiro, R Takahashi, K Yoshino, K Tanimura, A Nakashima, S Eguchi, T Miyamoto, K Hara, K Takehana, J Avruch, U Kikkawa, K Yonezawa	The Journal of biological chemistry	2007
Cardiovascular Medicine JT Willerson, HJ Wellens, JN Cohn, DR Holmes		2007
Effect of Rapamycin/Curcumin Co-Loaded Poly(Lactide-Co-Glycolide) Films on Blood Compatibility and Vascular Smooth Muscle Cell Proliferation J Wang, JJ Tang, L Ren, CJ Pan, N Huang	Key Engineering Materials	2007
Essentials of Restenosis HJ Duckers, EG Nabel, PW Serruys		2007
Inflammatory responses involving tumor necrosis factor receptor-associated factor 6 contribute to in-stent lesion formation in a stent implantation model of rabbit carotid artery T Miyahara, H Koyama, T Miyata, H Shigematsu, JI Inoue, T Takato, H Nagawa	Journal of Vascular Surgery	2006
Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways L Liu, F Li, JA Cardelli, KA Martin, J Blenis, S Huang	Oncogene	2006
Effectiveness of a Sirolimus-Eluting Stent (Cypher ® ) for Diffuse In-Stent Restenosis Inside a Bare Metal Stent H Sakamoto, T Ishikawa, M Mutoh, H Okada, T Tsurusaki, M Ohta, M Higashitani, Y Nakano, Y Fuda, K Imai, T Horie, S Mochizuki	International Heart Journal	2006
Safety and Pharmacokinetics of Sirolimus-eluting Stents in the Canine Cerebral Vasculature: 180 Day Assessment EI Levy, RA Hanel, FO Tio, DS Garlick, L Bailey, MR Cunningham, C Williard, D Sherman, JF Dooley, GA Kopia	Neurosurgery	2006
Oral Rapamycin After Coronary Bare-Metal Stent Implantation to Prevent Restenosis AE Rodriguez, JF Granada, M Rodriguez-Alemparte, CF Vigo, J Delgado, C Fernandez-Pereira, A Pocovi, AM Rodriguez-Granillo, D Schulz, AE Raizner, I Palacios, W O’Neill, GL Kaluza, G Stone	Journal of the American College of Cardiology	2006
The Paclitaxel-Eluting Stent in Percutaneous Coronary Intervention: Part II GM Ray, JJ Nawarskas, WH Frishman	Cardiology in Review	2006
Dominant-negative Rac increases both inherent and ionizing radiation-induced cell migration in C6 rat glioma cells SY Hwang, JW Jung, JS Jeong, YJ Kim, ES Oh, TH Kim, JY Kim, KH Cho, IO Han	International Journal of Cancer	2006
Sirolimus and Paclitaxel on Polymer-Based Drug-Eluting Stents R Wessely, A Schömig, A Kastrati	Journal of the American College of Cardiology	2006
Coronary artery restenosis: vascular biology and emerging therapeutic strategies K Sarkar, SK Sharma, R Sachdeva, F Romeo, L Garza, JL Mehta	Expert Review of Cardiovascular Therapy	2006
Molecular activity of sirolimus and its possible application in tuberous sclerosis treatment J Jozwiak, S Jozwiak, M Oldak	Medicinal Research Reviews	2006
The role and value of sirolimus administration in kidney and liver transplantation A Mehrabi, H Fonouni, A Kashfi, BM Schmied, C Morath, M Sadeghi, P Schemmer, J Encke, P Sauer, M Zeier, J Weitz, MW Büchler, J Schmidt	Clinical Transplantation	2006
Effects of Tacrolimus or Sirolimus on Proliferation of Vascular Smooth Muscle and Endothelial Cells CM Matter, I Rozenberg, A Jaschko, H Greutert, DJ Kurz, S Wnendt, B Kuttler, H Joch, J Gr??nenfelder, G Z??nd, FC Tanner, TF L??scher	Journal of Cardiovascular Pharmacology	2006
Controlled release of sirolimus from a multilayered PLGA stent matrix X Wang, SS Venkatraman, FY Boey, JS Loo, LP Tan	Biomaterials	2006
Mycophenolate Mofetil and Sirolimus Combination in Renal Transplantation JM Grinyo, JM Cruzado	American Journal of Transplantation	2006
Anesthesia for Pediatric Organ Transplantation KM Robertson, AC Shukla, FX McGowan, DS Beebe, KG Belani, VL Scott	Smith s Anesthesia for Infants and Children	2006
Enzyme Inhibitors Series M Boehm, M Crook	Enzyme Inhibitors Series	2006
Pathology of Drug-Eluting Stents in Humans M Joner, AV Finn, A Farb, EK Mont, FD Kolodgie, E Ladich, R Kutys, K Skorija, HK Gold, R Virmani	Journal of the American College of Cardiology	2006
Liposome Technology, Volume II: Entrapment of Drugs and Other Materials into Liposomes, Third Edition R Schumacher, G Spagnoli, M Adamina	Liposome Technology, Volume II: Entrapment of Drugs and Other Materials into Liposomes, Third Edition	2006
Recanalização da artéria femoral superficial com stents Zilver: técnica padronizada e análise retrospectiva de 3 anos M Ferreira, LF Capotorto, G Abuhadba, M Monteiro, L Lanziotti	Jornal Vascular Brasileiro	2006
Pharmacological basis of different targets for the treatment of atherosclerosis HK Saini, YJ Xu, AS Arneja, PS Tappia, NS Dhalla	Journal of Cellular and Molecular Medicine	2005
Sirolimus-Eluting Stents Associated With Paradoxic Coronary Vasoconstriction M Togni, S Windecker, R Cocchia, P Wenaweser, S Cook, M Billinger, B Meier, OM Hess	Journal of the American College of Cardiology	2005
The drug-based pipeline against restenosis PF Keller, R Ibrahim, JC Tardif	Expert Opinion on Emerging Drugs	2005
Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials C Stettler, S Allemann, M Egger, S Windecker, B Meier, P Diem	Heart (British Cardiac Society)	2005
Role of oral rapamycin to prevent restenosis in patients with de novo lesions undergoing coronary stenting: results of the Argentina single centre study (ORAR trial) AE Rodríguez, MR Alemparte, CF Vigo, CF Pereira, C Llauradó, D Vetcher, A Pocovi, J Ambrose	Heart (British Cardiac Society)	2005
Drug-eluting stent: a review and update T Htay, MW Liu	Vascular Health and Risk Management	2005
Altered trafficking of CD8+ memory T cells after implantation of rapamycin-eluting stents in patients with coronary artery disease G Sardella, D Accapezzato, AD Roma, V Francavilla, CD Russo, G Iannucci, MI Sirinian, L Giacomelli, F Fedele, M Paroli	Immunology Letters	2005
Stents recubiertos y otros dispositivos antirreestenosis R Moreno	Revista Española de Cardiología	2005
Cardiovascular risk profile in patients treated with sirolimus after renal transplantation JM Morales	Kidney International	2005
Novel site-specific systemic delivery of Rapamycin with perfluorobutane gas microbubble carrier reduced neointimal formation in a porcine coronary restenosis model NN Kipshidze, TR Porter, G Dangas, H Yazdi, F Tio, F Xie, D Hellinga, R Wolfram, R Seabron, R Waksman, A Abizaid, G Roubin, S Iyer, A Colombo, MB Leon, JW Moses, P Iversen	Catheterization and Cardiovascular Interventions	2005
Rapamycin Attenuates Atherosclerotic Plaque Progression in Apolipoprotein E Knockout Mice R Pakala, E Stabile, GJ Jang, L Clavijo, R Waksman	Journal of Cardiovascular Pharmacology	2005
A Prospective Randomized Trial of Steroid-Free Maintenance Regimens in Kidney Transplant Recipients-An Interim Analysis R Kandaswamy, JK Melancon, T Dunn, M Tan, V Casingal, A Humar, WD Payne, RW Gruessner, DL Dunn, JS Najarian, DE Sutherland, KJ Gillingham, AJ Matas	American Journal of Transplantation	2005
Mycotic aneurysm of left anterior descending artery after sirolimus-eluting stent implantation: A case report H Singh, C Singh, N Aggarwal, JS Dugal, A Kumar, M Luthra	Catheterization and Cardiovascular Interventions	2005
Stent Implantation Activates RhoA in Human Arteries: Inhibitory Effect of Rapamycin P Guérin, V Sauzeau, M Rolli-Derkinderen, OA Habbash, E Scalbert, D Crochet, P Pacaud, G Loirand	Journal of Vascular Research	2005
Sphingosine-1-phosphate–induced smooth muscle cell migration involves the mammalian target of rapamycin WJ Tanski, SM Nicholl, D Kim, AJ Fegley, E Roztocil, MG Davies	Journal of Vascular Surgery	2005
Drug-eluting stents: Sirolimus and paclitaxel differentially affect cultured cells and injured arteries TJ Parry, R Brosius, R Thyagarajan, D Carter, D Argentieri, R Falotico, J Siekierka	European Journal of Pharmacology	2005
A novel drug-eluting stent spray-coated with multi-layers of collagen and sirolimus MC Chen, HF Liang, YL Chiu, Y Chang, HJ Wei, HW Sung	Journal of Controlled Release	2005
Handbook of Drug-Eluting Stents: preclinical studies A Carter, G Kopia, R Falotico	Handbook of Drug-Eluting Stents: preclinical studies	2005
Handbook of Drug-Eluting Stents Y Yang, A Marks, S Marx	Handbook of Drug-Eluting Stents: preclinical studies	2005
Drug-Eluting Stents: Advanced Applications for the Management of Coronary Disease A Chan	Drug-Eluting Stents: Advanced Applications for the Management of Coronary Disease	2005
Drug-Eluting Stents and Other Anti-Restenosis Devices R Moreno	Revista Española de Cardiología (English Edition)	2005
Rapamycin inhibits fibronectin-induced migration of the human arterial smooth muscle line (E47) through the mammalian target of rapamycin K Sakakibara, B Liu, S Hollenbeck, KC Kent	American journal of physiology. Heart and circulatory physiology	2005
Heme oxygenase-1: a therapeutic amplification funnel FH Bach	The FASEB Journal	2005
Diabetes and percutaneous coronary intervention in the setting of an acute coronary syndrome DM Safley, SP Marso	Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease	2005
Drug Eluting Stent Technology: A Paradigm Shift in the Treatment and Prevention of Restenosis W Alvarez, NK Kapur	Journal of Pharmacy Practice	2005
mTOR-targeted therapy of cancer with rapamycin derivatives S Vignot, S Faivre, D Aguirre, E Raymond	Annals of oncology : official journal of the European Society for Medical Oncology / ESMO	2005
In smooth muscle, FK506-binding protein modulates IP3 receptor-evoked Ca2+ release by mTOR and calcineurin D MacMillan, S Currie, KN Bradley, TC Muir, JG McCarron	Journal of cell science	2005
Bone marrow-derived immune cells regulate vascular disease through a p27Kip1-dependent mechanism Manfred Boehm, Michelle Olive, Andrea L. True, Martin F. Crook, Hong San, Xuan Qu, Elizabeth G. Nabel	Journal of Clinical Investigation	2004
Rapamycin attenuates atherosclerosis induced by dietary cholesterol in apolipoprotein-deficient mice through a p27Kip1-independent pathway C Castro, JM Campistol, D Sancho, F Sánchez-Madrid, E Casals, V Andrés	Atherosclerosis	2004
Drug-Eluting Stents: A Mechanical and Pharmacologic Approach to Coronary Artery Disease PP Dobesh, ZA Stacy, AJ Ansara, JM Enders	Pharmacotherapy	2004
Perivascular delivery of neomycin inhibits the activation of NF-κB and MAPK pathways, and prevents neointimal hyperplasia and stenosis after arterial injury J García-Trapero, F Carceller, M Dujovny, P Cuevas	Neurological Research	2004
Prevention of restenosis after coronary angioplasty G Karthikeyan, B Bhargava	Current Opinion in Cardiology	2004
Local application of rapamycin inhibits neointimal hyperplasia in experimental vein grafts T Schachner, Y Zou, A Oberhuber, A Tzankov, T Mairinger, G Laufer, JO Bonatti	The Annals of Thoracic Surgery	2004
Role of the p70S6K pathway in regulating the actin cytoskeleton and cell migration LA Berven, FS Willard, MF Crouch	Experimental Cell Research	2004
Cell-cycle-dependent regulation of cell motility and determination of the role of Rac1 PS Walmod, R Hartmann-Petersen, S Prag, EL Lepekhin, C Röpke, V Berezin, E Bock	Experimental Cell Research	2004
TOR of the cell cycle: Are there important implications for diabetics in the era of the drug-eluting stent? AJ Carter	Catheterization and Cardiovascular Interventions	2004
Oral rapamycin to inhibit restenosis after stenting of de novo coronary lesions R Waksman, AE Ajani, AD Pichard, R Torguson, E Pinnow, D Canos, LF Satler, KM Kent, P Kuchulakanti, C Pappas, L Gambone, N Weissman, MC Abbott, J Lindsay	Journal of the American College of Cardiology	2004
Rapamycin suppresses experimental aortic aneurysm growth DM Lawrence, RS Singh, DP Franklin, DJ Carey, JR Elmore	Journal of Vascular Surgery	2004
Importance of mammalian target of rapamycin inhibitors in the prevention of cardiac allograft vasculopathy AM Keogh, PN Ruygrok	Current Opinion in Organ Transplantation	2004
Conjugation of an antibody to cross-linked fibrin for targeted delivery of anti-restenotic drugs AC Thomas, JH Campbell	Journal of Controlled Release	2004
Du sirolimus au stent Cypher®: les étapes d'une victoire contre la restenose I Fontes	Annales de Cardiologie et d Angéiologie	2004
Differential effects of rapamycin, cyclosporine A, and FK506 on human coronary artery smooth muscle cell proliferation and signalling S Hafizi, VN Mordi, KM Andersson, AH Chester, MH Yacoub	Vascular Pharmacology	2004
Case Studies in Interventional Cardiology: a Potential Cure of Restenosis M Costa, A Abizaid, A Abizaid, R Staico, A Chaves, M Centemero, A Silva, A Sousa, J Sousa	Case Studies in Interventional Cardiology: a Potential Cure of Restenosis	2004
Dose-dependent Inhibition of Myointimal Hyperplasia by Orally Administered Rapamycin N Uchimura, GB Perera, RM Fujitani, JM Tobis, S Ishimaru, SE Wilson, IL Gordon	Annals of Vascular Surgery	2004
Intimal Hyperplasia—Still Here after All These Years! KC Kent, B Liu	Annals of Vascular Surgery	2004
Preventing restenosis in early drug-eluting stent era: recent developments and future perspectives P Birkenhauer, Z Yang, B Gander	Journal of Pharmacy and Pharmacology	2004
The Rapamycin derivative RAD inhibits mesangial cell migration through the CDK-inhibitor p27KIP1 C Daniel, J Pippin, SJ Shankland, C Hugo	Laboratory Investigation	2004
Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression DC Fingar, J Blenis	Oncogene	2004
The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation KA Martin, EM Rzucidlo, BL Merenick, DC Fingar, DJ Brown, RJ Wagner, RJ Powell	American journal of physiology. Cell physiology	2004
Effect of sirolimus on renal ischaemia/reperfusion injury in normotensive and hypertensive rats O Viklick, R Bohmov, N Ouyang, E Honsov, A Lodererov, V Mandys, tefan Vtko, J Lutz, UW Heemann	Transplant International	2004
Inhibition of Mammalian Target of Rapamycin Activates Apoptosis Signal-regulating Kinase 1 Signaling by Suppressing Protein Phosphatase 5 Activity S Huang, L Shu, J Easton, FC Harwood, GS Germain, H Ichijo, PJ Houghton	The Journal of biological chemistry	2004
Rapamycin plays a new role as differentiator of vascular smooth muscle phenotype. Focus on “The mTOR/p70 S6K1 pathway regulates vascular smooth muscle differentiation” PA Lucchesi	American journal of physiology. Cell physiology	2004
BK Virus-Associated Nephropathy in Renal Allograft Recipients: Rescue Therapy by Sirolimus-Based Immunosuppression: RK Wali, C Drachenberg, HH Hirsch, J Papadimitriou, A Nahar, V Mohanlal, MA Brisco, ST Bartlett, MR Weir, E Ramos	Transplantation	2004
Therapeutic Potential of Oral Antiproliferative Agents in the Prevention of Coronary Restenosis: P Kuchulakanti, R Waksman	Drugs	2004
Investigation of Pediatric Renal Transplant Recipients with Heavy Proteinuria after Sirolimus Rescue: L Butani	Transplantation	2004
Rapamycin attenuates vascular wall inflammation and progenitor cell promoters after angioplasty TG Nührenberg, R Voisard, F Fahlisch, M Rudelius, J Braun, J Gschwend, M Kountides, T Herter, R Baur, V Hombach, PA Baeuerle, D Zohlnhöfer	The FASEB Journal	2004
Therapeutic potential of active stent coating H Wieneke, A Schmermund, C Birgelen, M Haude, R Erbel	Expert Opinion on Investigational Drugs	2003
New approaches to preventing restenosis B Bhargava, G Karthikeyan, AS Abizaid, R Mehran	BMJ (Clinical research ed.)	2003
Drug-eluting stents for cardiovascular disorders JF Granada, GL Kaluza, A Raizner	Current Atherosclerosis Reports	2003
Rapamycin inhibits E2F-dependent expression of minichromosome maintenance proteins in vascular smooth muscle cells D Bruemmer, F Yin, J Liu, T Kiyono, E Fleck, AJ van Herle, RE Law	Biochemical and Biophysical Research Communications	2003
Angiographic regression of cardiac allograft vasculopathy after introducing sirolimus immunosuppression PN Ruygrok, B Webber, S Faddy, DW Muller, A Keogh	The Journal of Heart and Lung Transplantation	2003
Rapamycin in cardiovascular medicine PN Ruygrok, DW Muller, PW Serruys	Internal Medicine Journal	2003
Sirolimus for the Prevention of In-Stent Restenosis in a Coronary Artery AR Marks	New England Journal of Medicine	2003
Surface engineering of biomaterials with plasma techniques F Poncin-Epaillard, G Legeay	Journal of Biomaterials Science, Polymer Edition	2003
Effect of systemic immunosuppression on coronary in-stent intimal hyperplasia in renal transplant patients JA Arruda, MA Costa, FS Brito, H Tedesco, AH Barbosa, ÉP Ribeiro, JO Pestana, VC Lima	The American Journal of Cardiology	2003
Stent-based immunosuppressive therapies for the prevention of restenosis M Aggarwal, PS Tsao, A Yeung, AJ Carter	Cardiovascular Radiation Medicine	2003
Drugs and the Pharmaceutical Sciences D Thompson	Drugs and the Pharmaceutical Sciences	2003
Rapamycin: signaling in vascular smooth muscle AR Marks	Transplantation Proceedings	2003
Sirolimus therapy in cardiac transplantation B Radovancevic, B Vrtovec	Transplantation Proceedings	2003
Oral rapamycin inhibits growth of atherosclerotic plaque in apoE knock-out mice R Waksman, R Pakala, MS Burnett, CP Gulick, L Leborgne, J Fournadjiev, R Wolfram, D Hellinga	Cardiovascular Radiation Medicine	2003
Use of rapamycin-impregnated stents in coronary arteries JE Sousa, AG Sousa, MA Costa, AC Abizaid, F Feres	Transplantation Proceedings	2003
Sirolimus in liver transplantation JF Trotter	Transplantation Proceedings	2003
Sirolimus changes lipid concentrations and lipoprotein metabolism in kidney transplant recipients JD Morrisett, G Abdel-Fattah, BD Kahan	Transplantation Proceedings	2003
Effect of carvedilol alone or in the presence of cyclosporine on the migration of vascular smooth muscle cell of rat MS Kim, H Ha, YS Kim, J Park, H Kim, J Seo, JH Lee, K Park	Transplantation Proceedings	2003
Targeting the cell cycle machinery for the treatment of cardiovascular disease KA Bicknell, EL Surry, G Brooks	Journal of Pharmacy and Pharmacology	2003
Inflammation and restenosis: implications for therapy MM Donners, MJ Daemen, KB Cleutjens, S Heeneman	Annals of Medicine	2003
Sirolimus as primary immunosuppression in liver transplantation is not associated with hepatic artery or wound complications J Dunkelberg	Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society	2003
Interligação entre cardiologia intervencionista e cirurgia experimental JE Souza	Acta Cirurgica Brasileira	2003
Transgene delivery of plasmid DNA to smooth muscle cells and macrophages from a biostable polymer-coated stent A Takahashi, M Palmer-Opolski, RC Smith, K Walsh	Gene Therapy	2003
The Sirolimus-Eluting Stent: A Review of Its Use in the Treatment of Coronary Artery Disease K McKeage, D Murdoch, KL Goa	American Journal Cardiovascular Drugs	2003
Development of a Water-Soluble Matrix Metalloproteinase Inhibitor as an Intra-arterial Infusion Drug for Prevention of Restenosis after Angioplasty T Masuda, Y Nakayama	Journal of Medicinal Chemistry	2003
Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies VJ Dzau, RC Braun-Dullaeus, DG Sedding	Nature Medicine	2002
New approaches to immunosuppression in liver transplantation S Goddard, DH Adams	Journal of Gastroenterology and Hepatology	2002
Rapamycin eluting stent: the onset of a new era in interventional cardiology PW Serruys, E Regar, AJ Carter	Heart (British Cardiac Society)	2002
Viewpoint Overcoming restenosis with sirolimus: from alphabet soup to clinical reality M Poon, JJ Badimon, V Fuster	The Lancet	2002
Stent-based antirestenotic coatings (sirolimus/paclitaxel) M Oberhoff, C Herdeg, A Baumbach, KR Karsch	Catheterization and Cardiovascular Interventions	2002
Everolimus in renal transplantation TR Srinivas, HU Meier-Kriesche, B Kaplan	Current Opinion in Organ Transplantation	2002
Coronary artery stents: Evaluating new designs for contemporary percutaneous intervention DE Kandzari, JE Tcheng, JP Zidar	Catheterization and Cardiovascular Interventions	2002
Sirolimus-Eluting Coronary Stents PD Feyter, P Smits, B Rensing, J Vos, WJ van der Giessen, G Sianos, PW Serruys	Journal of Interventional Cardiology	2002
A clinical survey of vascular stents SH Duda, B Wiesinger, C Koenig, J Wiskirchen, T Dietrich, G Tepe	Minimally Invasive Therapy & Allied Technologies	2002
Quantification of Sirolimus by Liquid Chromatography-Tandem Mass Spectrometry Using On-Line Solid-Phase Extraction M Vogeser, C Fleischer, B Meiser, J Groetzner, U Spöhrer, D Seidel	Clinical Chemistry and Laboratory Medicine	2002
Smooth muscle cells on the move: the battle for actin PA Doevendans, G Eys	Cardiovascular Research	2002
Fate of side branches after coronary arterial sirolimus-eluting stent implantation K Tanabe, PW Serruys, M Degertekin, E Regar, RT van Domburg, JE Sousa, E Wülfert, MC Morice	The American Journal of Cardiology	2002
El estudio ravel. Reestenosis del cero por ciento: ¡un sueño del cardiólogo hecho realidad! E Regar, PW Serruys	Revista Española de Cardiología	2002
Cardiovascular risk factors associated with immunosuppression in renal transplantation BL Kasiske, CM Ballantyne	Transplantation Reviews	2002
Role of smooth muscle cell migration and proliferation in allograft vascular disease M Roqué, ED Reis, E Roig	Transplantation Proceedings	2002
Drug-eluting stents for the prevention of restenosis: In quest for the holy grail BL Hiatt, F Ikeno, AC Yeung, AJ Carter	Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions	2002
CDKS and CKIS: Molecular targets for tissue remodelling EG Nabel	Nature Reviews Drug Discovery	2002
No delayed restenosis at 18 months after implantation of sirolimus-eluting stent K Tanabe, M Degertekin, E Regar, JM Ligthart, WJ van der Giessen, PW Serruys	Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions	2002
Sirolimus-Eluting Stents for the Treatment of Obstructive Superficial Femoral Artery Disease: Six-Month Results SH Duda, B Pusich, G Richter, P Landwehr, VL Oliva, A Tielbeek, B Wiesinger, JB Hak, H Tielemans, G Ziemer, E Cristea, A Lansky, JP Bérégi	Circulation	2002
Oral Everolimus Inhibits In-Stent Neointimal Growth A Farb, M John, E Acampado, FD Kolodgie, MF Prescott, R Virmani	Circulation	2002
Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients JD Morrisett, G Abdel-Fattah, R Hoogeveen, E Mitchell, CM Ballantyne, HJ Pownall, AR Opekun, JS Jaffe, S Oppermann, BD Kahan	Journal of lipid research	2002
Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin RC Braun-Dullaeus, MJ Mann, U Seay, L Zhang, HE von der Leyen, RE Morris, VJ Dzau	Arteriosclerosis, thrombosis, and vascular biology	2001
Long-term immunosuppressive strategy in the new millennium of renal transplantation S Gourishankar, P Halloran	Current Opinion in Organ Transplantation	2001
Effects of local cytochalasin D delivery on smooth muscle cell migration and on collar-induced intimal hyperplasia in the rabbit carotid artery RH Bruijns, H Bult	British Journal of Pharmacology	2001
Pharmacological treatment for prevention of restenosis J Linde, BH Strauss	Expert Opinion on Emerging Drugs	2001
From Beach to Bedside: History of the Development of Sirolimus KL Napoli, PJ Taylor	Therapeutic Drug Monitoring	2001
Effect of p27 Deficiency and Rapamycin on Intimal Hyperplasia: In Vivo and In Vitro Studies Using a p27 Knockout Mouse Model M Roqué, ED Reis, C Cordon-Cardo, MB Taubman, JT Fallon, V Fuster, JJ Badimon	Laboratory Investigation	2001
Handbook of Coronary Stents, Fourth Edition: Clinical Data M Costa, J Sousa	Handbook of Coronary Stents, Fourth Edition: Clinical Data	2001
Handbook of Coronary Stents, Fourth Edition: Preclinical Data A Carter, R Falotico	Handbook of Coronary Stents, Fourth Edition: Preclinical Data	2001
Stent development and local drug delivery E Regar, G Sianos, PW Serruys	British Medical Bulletin	2001
Inhibition of p70 S6 Kinase during Transforming Growth Factor-β1/Vitamin D 3 -induced Monocyte Differentiation of HL-60 Cells Allows Tumor Necrosis Factor-α to Stimulate Plasminogen Activator Inhibitor-1 Synthesis F Peiretti, S Lopez, P Deprez-Beauclair, B Bonardo, I Juhan-Vague, G Nalbone	The Journal of biological chemistry	2001
Role for p27 Kip1 in Vascular Smooth Muscle Cell Migration J Sun, SO Marx, HJ Chen, M Poon, AR Marks, LR Rabbani	Circulation	2001
Cell Cycle and Cell Migration: New Pieces to the Puzzle M Boehm, EG Nabel	Circulation	2001
Stent-Based Delivery of Sirolimus Reduces Neointimal Formation in a Porcine Coronary Model T Suzuki, G Kopia, S Hayashi, LR Bailey, G Llanos, R Wilensky, BD Klugherz, G Papandreou, P Narayan, MB Leon, AC Yeung, F Tio, PS Tsao, R Falotico, AJ Carter	Circulation	2001
Lack of Neointimal Proliferation After Implantation of Sirolimus-Coated Stents in Human Coronary Arteries: A Quantitative Coronary Angiography and Three-Dimensional Intravascular Ultrasound Study JE Sousa, MA Costa, A Abizaid, AS Abizaid, F Feres, IM Pinto, AC Seixas, R Staico, LA Mattos, AG Sousa, R Falotico, J Jaeger, JJ Popma, PW Serruys	Circulation	2001
Bench to Bedside: The Development of Rapamycin and Its Application to Stent Restenosis SO Marx, AR Marks	Circulation	2001
Sustained Suppression of Neointimal Proliferation by Sirolimus-Eluting Stents: One-Year Angiographic and Intravascular Ultrasound Follow-Up JE Sousa, MA Costa, AC Abizaid, BJ Rensing, AS Abizaid, LF Tanajura, K Kozuma, GV Langenhove, AG Sousa, R Falotico, J Jaeger, JJ Popma, PW Serruys	Circulation	2001
Cardiac Allograft Rejection GW Dec, J Narula, M Ballester, I Carrio		2001
Current treatment practice in immunosuppression G Ciancio, GW Burke, J Miller	Expert Opinion on Pharmacotherapy	2000
Modulation of apoptosis, proliferation, and p27 expression in a porcine coronary angioplasty model M Roque, C Cordon-Cardo, V Fuster, ED Reis, M Drobnjak, JJ Badimon	Atherosclerosis	2000
Efficacies of sirolimus (rapamycin) and cyclosporine in allograft vascular disease in non-human primates: trough levels of sirolimus correlate with inhibition of progression of arterial intimal thickening TS Ikonen, JF Gummert, N Serkova, M Hayase, Y Honda, Y Kobayase, B Hausen, PG Yock, U Christians, RE Morris	Transplant International	2000
Interleukin-8 Gene Repression by Clarithromycin Is Mediated by the Activator Protein-1 Binding Site in Human Bronchial Epithelial Cells S Abe, H Nakamura, S Inoue, H Takeda, H Saito, S Kato, N Mukaida, K Matsushima, H Tomoike	American journal of respiratory cell and molecular biology	2000
α 2 Integrin Subunit Cytoplasmic Domain-dependent Cellular Migration Requires p38 MAPK PA Klekotka, SA Santoro, MM Zutter	The Journal of biological chemistry	2000
Maintenance Immunosuppression: New Agents and Persistent Dilemmas JM Gonin	Advances in renal replacement therapy	2000
SDZ-RAD PREVENTS MANIFESTATION OF CHRONIC REJECTION IN RAT RENAL ALLOGRAFTS: O Viklick, H Zou, V Muller, J Lacha, A Szab, U Heemann	Transplantation	2000
SIROLIMUS (RAPAMYCIN) HALTS AND REVERSES PROGRESSION OF ALLOGRAFT VASCULAR DISEASE IN NON-HUMAN PRIMATES1: TS Ikonen, JF Gummert, M Hayase, Y Honda, B Hausen, U Christians, GJ Berry, PG Yock, RE Morris	Transplantation	2000
Phosphatidylinositol 3-Kinase Is Required for Insulin-Like Growth Factor-I–Induced Vascular Smooth Muscle Cell Proliferation and Migration C Duan, JR Bauchat, T Hsieh	Circulation research	2000
Drug Discovery from Nature S Grabley, R Thiericke		2000
The therapeutic prescription for the organ transplant recipient: the linkage of immunosuppression and antimicrobial strategies RH Rubin, T Ikonen, JF Gummert, RE Morris	Transplant Infectious Disease	1999
Kinase targets in inflammation PA Scherle, JM Trzaskos	Expert Opinion on Therapeutic Targets	1999
Potential utility of rapamycin and tacrolimus in long-term, low-toxicity regimens RS Gaston	Transplantation Proceedings	1999
Inhibition of Intimal Thickening After Balloon Angioplasty in Porcine Coronary Arteries by Targeting Regulators of the Cell Cycle R Gallo, A Padurean, T Jayaraman, S Marx, M Roque, S Adelman, J Chesebro, J Fallon, V Fuster, A Marks, JJ Badimon	Circulation	1999
A Macrolide Antibiotic, Roxithromycin, Inhibits the Growth of Nasal Polyp Fibroblasts M Nonaka, R Pawankar, S Tomiyama, T Yagi	American journal of rhinology	1999
Newer Immunosuppressive Drugs: A Review JF Gummert, T Ikonen, RE Morris	Journal of the American Society of Nephrology : JASN	1999
Growth factors and transplant vascular disease S Saito, H Lou, PW Ramwell, ML Foegh	Transplantation Reviews	1998
Cell cycle progression: new therapeutic target for vascular proliferative disease RC Braun-Dullaeus, MJ Mann, VJ Dzau	Circulation	1998
Platelet-Derived Growth Factor-BB, Insulin-like Growth Factor-I, and Phorbol Ester Activate Different Signaling Pathways for Stimulation of Vascular Smooth Muscle Cell Migration L Pukac, J Huangpu, MJ Karnovsky	Experimental Cell Research	1998
Medical therapies for the prevention of restenosis after percutaneous coronary interventions WH Frishman, R Chiu, BR Landzberg, M Weiss	Current Problems in Cardiology	1998

Advertisement